Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Jain

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 5, 2025
Quality-adjusted time without symptoms of disease progression or toxicity of treatment in patients with primary advanced or recurrent endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel versus carboplatin-paclitaxelDana M Chase, Jørn Herrstedt, Eirwen M Miller, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 8, 2019
NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019Deborah K Armstrong, Ronald D Alvarez, Jamie N Bakkum-Gamez, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 5, 2021
Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in OncologyDeborah K Armstrong, Ronald D Alvarez, Jamie N Bakkum-Gamez, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 16, 2024
NCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024Joyce Liu, Andrew Berchuck, Floor J Backes, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 8, 2022
NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022Deborah K Armstrong, Ronald D Alvarez, Floor J Backes, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 5, 2025
Quality-adjusted time without symptoms of disease progression or toxicity of treatment in patients with primary advanced or recurrent endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel versus carboplatin-paclitaxelDana M Chase, Jørn Herrstedt, Eirwen M Miller, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 8, 2019
NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019Deborah K Armstrong, Ronald D Alvarez, Jamie N Bakkum-Gamez, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 5, 2021
Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in OncologyDeborah K Armstrong, Ronald D Alvarez, Jamie N Bakkum-Gamez, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 16, 2024
NCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024Joyce Liu, Andrew Berchuck, Floor J Backes, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 8, 2022
NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022Deborah K Armstrong, Ronald D Alvarez, Floor J Backes, et al.
Pageof 2